How many days can Kawasaki disease be cured?

Written by Li Jiao Yan
Neonatology
Updated on September 26, 2024
00:00
00:00

Kawasaki disease is a syndrome of mucocutaneous lymph node syndrome, the cause of which is unclear, as is the pathogenesis of the disease. The pathological changes are mainly systemic vasculitis, which is prone to secondary damage to the coronary arteries. It has a relatively long course. If fever occurs, the fever can persist for 1-2 weeks. Generally, special medications such as aspirin are required for treatment. Usually, treatment is for 3 days, and after the fever subsides, the dosage is gradually reduced, maintained for 6-8 weeks. If there is secondary coronary artery damage, the duration might be longer. In cases of severe coronary damage, the duration of the disease may be several months or even years, depending on the specific condition of the disease. Kawasaki disease is a self-limiting disease. Usually, if there is no significant coronary artery damage, after symptom control, comprehensive examinations are conducted 1 month, 3 months, 6 months, and 1-2 years after discharge, mainly heart examinations such as electrocardiograms and echocardiograms. If there is a combination of coronary artery aneurysms, long-term follow-up is required, with an examination every six months to one year until the coronary aneurysm disappears or if there is combined damage to the coronary artery structure, long-term follow-up is needed.

Other Voices

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
42sec home-news-image

How long to take aspirin for Kawasaki disease

The current pathogenesis of Kawasaki disease is not yet clear, but one of its main pathological changes is a systemic vasculitis. During an outbreak of Kawasaki disease, the blood viscosity increases primarily due to platelet aggregation. Typically, oral aspirin is administered to prevent this inflammation and to treat platelet aggregation. The dosage is generally reduced gradually once the fever subsides, with maintenance doses lasting about six to eight weeks. If coronary artery lesions are present, the duration of medication is extended until the coronary arteries return to normal before discontinuing the drug.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
1min 52sec home-news-image

How many days does it take to be discharged from the hospital for Kawasaki disease?

Kawasaki disease is a disease with unclear pathogenesis and etiology. A major pathological change is systemic vasculitis, which commonly affects the coronary arteries. Typically, it presents with fever lasting from seven to fourteen days or longer, and antibiotics are ineffective in treatment. During the first through sixth weeks of the illness, complications such as pericarditis, myocarditis, endocarditis, and arrhythmias may occur. Coronary artery damage often occurs between the second and fourth weeks of the illness, and proactive and effective treatment of Kawasaki disease can prevent coronary complications. The acute phase generally involves symptomatic supportive care, prevention of platelet aggregation, fever reduction, and prevention of coronary artery damage. Treatment with intravenous immunoglobulin is recommended within the first ten days of onset. If the treatment is not effective, other special medications like steroids may be used, and the treatment duration is generally between two to four weeks. Thus, the pathogenesis of Kawasaki disease is uncertain, and its pathological process is prolonged. The specific timing of discharge depends on the child's condition. If the fever is controlled and no significant coronary artery damage is evident, and the condition is stable, then discharge is possible. However, post-discharge, follow-up should be conducted based on the child's specific condition. Therefore, the duration of hospitalization for Kawasaki disease is not fixed and depends on the child's condition and treatment response.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
1min 14sec home-news-image

Can Kawasaki disease be cured?

Kawasaki disease, also known as mucocutaneous lymph node syndrome, has an unclear pathogenesis. The primary pathological change is systemic vasculitis. It commonly affects infants and young children, with 80% of cases occurring in children under five years of age. Kawasaki disease is a self-limiting condition, and most cases have a good prognosis. However, there is a 1% to 2% chance of recurrence. If not effectively treated, 15% to 25% of cases may develop coronary artery aneurysms. These aneurysms often resolve on their own within two years after the disease, but often leave behind abnormalities such as thickening of the vessel wall and decreased elasticity. Larger aneurysms may not completely resolve and can lead to thrombosis or narrowing of the vessel. Kawasaki disease is also one of the causes of acquired heart disease in children. Therefore, Kawasaki disease should be treated promptly and effectively to prevent severe complications.

doctor image
home-news-image
Written by Zeng Hai Jiang
Pediatrics
55sec home-news-image

Causes of secondary recurrence of Kawasaki disease

Kawasaki disease, also known as mucocutaneous lymph node syndrome, commonly affects children and infants under five years old. It is an acute, systemic vasculitic disease. Clinically, it is primarily characterized by persistent fever, bilateral conjunctival congestion, cracked lips, strawberry tongue, rash, hard swelling of hands and feet, fingertip desquamation, and enlargement of cervical lymph nodes. In severe cases, it can lead to coronary artery dilation, coronary artery aneurysms, and thrombotic obstruction. The exact cause of Kawasaki disease is not very clear, but it is mainly believed to be related to infections. The probability of secondary recurrence of Kawasaki disease is about 2%, and its causes mainly have to do with infections, immune factors of the body, genetic factors, and so on.

doctor image
home-news-image
Written by Yao Li Qin
Pediatrics
52sec home-news-image

Kawasaki disease causes

Kawasaki disease, also known as mucocutaneous lymph node syndrome, is an immune-mediated systemic vasculitis syndrome and a relatively common pediatric febrile rash disease. To date, the etiology of Kawasaki disease is not entirely clear. Extensive epidemiological and clinical observations suggest that Kawasaki disease may be an acute immune dysregulation caused by infectious factors. Genetic factors are also related to the occurrence of Kawasaki disease. Various bacteria, viruses, mycoplasma, and their metabolic products, such as superantigens produced by Streptococcus and Staphylococcus, are also related to the development of Kawasaki disease.